We demonstrated an ~80-fold higher in vitro binding of the 89Zr-hCD4-Mb in the hCD4+ HBP-ALL cells than in the hCD4- DHL B-cell-lymphoma cells while in vivo accumulation of s.c. injected cells was only ~4-fold higher. The gene discussed is MB; the disease is acute lymphoblastic leukemia.